🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. To demonstrate the feasibility of leukapheresis and ex vivo activation o...
Status
Completed
Location
National University Hospital
Start Date
2007-05
Trial ID
NCT00717184
Treatments Being Tested
This is an open-label, multi-center study to evaluate the safety, tolerabil...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
2021-11-03
Trial ID
NCT05099549
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
This is a Phase 1 open-label, study designed to characterize the safety, to...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-11-06
Trial ID
NCT05629546
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
The main purpose of this study is to explore if the combination of autologo...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2016-03
Trial ID
NCT02734524
Treatments Being Tested
Targeted Natural Killer (NK) cell based adoptive immunotherapy for the trea...
Status
Completed
Location
Klinikum rechts der Isar, Strahlentherapie und Radiologische Onkologie
Start Date
2014-03
Trial ID
NCT02118415
Treatments Being Tested
This phase I trial studies the side effects and best dose of expanded natur...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-03-17
Trial ID
NCT02271711
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-02-18
Trial ID
NCT07382817
Treatments Being Tested
This study represents a phase I clinical trial that utilizes natural killer...
Status
Recruiting
Location
Cipto Mangunkusumo General Hospital
Start Date
2022-08-29
Trial ID
NCT06044506
Treatments Being Tested